chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive covid test result received on03Nov2021; positive covid test result received on03Nov2021; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 22Mar2021 13:15 (Batch/Lot number was not reported) as DOSE 2, SINGLE, dose 1 intramuscular, administered in Arm Left on 01Mar2021 13:15 (Batch/Lot number was not reported) as DOSE 1,SINGLE at the age of 58-years-old for covid-19 immunisation.  Medical history included Known allergy: PCN.The patient's concomitant medications were not reported.  The patient experienced positive covid test result received on 03Nov2021.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 03Nov2021 Nasal Swab. Outcome of events was unknown. Therapeutic measures were taken as a result of all events.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recvd vax; seversl hrs later devel fever of 102; high pitched cry x 4 hrs; appeared well afterwards;
Pt telephoned today said he has redness & soreness at injection site, he believes it is infected says he removed the bandaid two days ago and that he developed a blister. Says he has not seen a medical provider due to no funds. Referred to clinic.
Pt. received first covid vaccine on March 23, 2021. Pt. developed symptoms on April 17, 2021 and tested + on 4/19/2021.  Pt. had multiple exposure leading up to positive test.  Pt. is currently stable and home.
WBC counts were too high above 100,000; fever; chills; BP 90/50; body aches; lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), BLOOD PRESSURE DECREASED (BP 90/50), MYALGIA (body aches) and LYMPHADENOPATHY (lymph nodes) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills), BLOOD PRESSURE DECREASED (BP 90/50), MYALGIA (body aches) and LYMPHADENOPATHY (lymph nodes). On 10-Apr-2021, the patient experienced LEUKOCYTOSIS (WBC counts were too high above 100,000). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), CHILLS (chills), BLOOD PRESSURE DECREASED (BP 90/50), MYALGIA (body aches), LYMPHADENOPATHY (lymph nodes) and LEUKOCYTOSIS (WBC counts were too high above 100,000) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Blood pressure measurement: 90/50 (Low) 90/50. On 10-Apr-2021, White blood cell count: above 100,000 (High) above 100,000.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Adult hepatitis A vaccine administered at 90 degree angle with 1-inch, 25 gauge needle. Immediately following vaccination, a bump approximately the size of a nickel formed at the site of vaccination. Patient did not complain of pain following vaccination.
Patient developed chest tightness approximately 25 minutes after receiving the injection.  This is been ongoing for a few days.  Also developed a blue discoloration under the right side of her tongue that she was concerned was due to the vaccine. Patient presented to urgent care where blood work was done.  Patient was found to have an elevated D-dimer and was thus sent to the ED.  Elevated D-dimer confirmed.
This case was reported by a pharmacist via call center representative and described the occurrence of taste abnormality in a elderly male patient who received SHINGRIX (batch number 9KT7T, expiry date 13th March 2021) for prophylaxis. On 6th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 6th December 2018, less than an hour after receiving SHINGRIX, the patient experienced taste abnormality. On an unknown date, the outcome of the taste abnormality was unknown. It was unknown if the reporter considered the taste abnormality to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported, but it could be 65 or 66 years. On the date of reporting, at 10:52, the patient received SHINGRIX in the left deltoid. The patient called the reporter back within 1 hour after receiving the vaccine to report that he had a medicine taste in his mouth. The reporter would not provide the date of birth for the patient except the birth year. The reporter did not consent to follow-up.
Noticed that patient became less responsive, less eye contact was shown, began stemming behavior, still non-verbal, began to be unresponsive to surrounding environment. . .retreated within himself.
my left leg started killing me, I cannot put it in the floor anymore; I can hardly walk; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second shot bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date (reported as 21st) at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE; unknown lot number and expiration date) at unknown vaccination age via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization and was ok. The patient reported that "I had got this injection on the 21st and I never had any problems but yesterday, my left leg started killing me, I cannot put it in the floor anymore Is this a thing from the injection?" The patient had this vaccination on 21st, the first shot ok and nothing happed to the patient but yesterday the patient's left leg is bothering the patient and the patient can hardly walk. The patient inquired that can this be because of the vaccination. The patient added that "That's all I want to know. It is really killing me." The outcome of the events was unknown.  The information on the lot/batch number has been requested.
Patient developed a rash over chest, arms, and neck approximately 1-2 hours after vaccination. Vital signs remained stable, BP 122/70, HR 62. Patient returned to vaccination site and was administered 50mg diphenhydramine. Rash resolved within an hour.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 03Jan2022 as dose number unknown (initial pfizer dose), single (Lot number: 3198) at the age of 61 years, in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 01Apr2021 as dose number unknown, single (Lot number: 042A21A), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEVOTHYROXINE. The following information was reported: COVID-19 (medically significant) with onset 02Jun2022, outcome "not recovered", DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) positive; (17Jun2022) positive. Therapeutic measures were taken as a result of covid-19.  Clinical course: He first tested positive for Covid Thursday morning 02Jun2022 after suffering with a high fever for 36 hours commencing Tuesday evening 31May. Was administered Paxlovid Thursday morning 02Jun. Completed the prescription Monday 06Jun and except for some minor wheezing, felt nearly 100% cured. By the following weekend, Saturday 11Jun, started to feel worse as my cough increased in my chest, and my head congestion increased. That was followed by a clogged eustachian tube this past week and fatigue. Hedon't believe I have redeveloped a fever, but I tested positive again for Covid as of my test Friday 17Jun.
anaphylactic; This spontaneous case was reported by a consumer and describes the occurrence of ANAPHYLACTIC REACTION (anaphylactic) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Denied) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAPHYLACTIC REACTION (anaphylactic) (seriousness criterion medically significant). At the time of the report, ANAPHYLACTIC REACTION (anaphylactic) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not provided. Treatment information was not provided.  Company comment: This case concerns a  female patient with no relevant medical history reported, who experienced the expected event of Anaphylactic reaction after the first dose of mRNA-1273. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.; Sender's Comments: This case concerns a  female patient with no relevant medical history reported, who experienced the expected event of Anaphylactic reaction after the first dose of mRNA-1273. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Immediately after PEDIARIX, PREVNAR, HIB - pt was crying - held breath - turned dark red - lost consciousness - 3 seconds and began breathing. Regained sensorium - breast feeding and alert within 2 min.
virus; virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 90-year-old female patient received bnt162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "virus". Therapeutic measures were taken as a result of drug ineffective, covid-19, which included Paxlovid.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Kinrix administered to a 4 month-old; Kinrix as 2nd dose in DTAP/IPV series; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 3KS4F, expiry date 22nd March 2024) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th January 2023, the patient received the 2nd dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 9th January 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-JAN-2023 Reporter's Comments: No reactions reported. The reporter consented to follow up via email. Additional Supportive Information: The patient received Kinrix as their 2nd dose in the DTAP/IPV series at inappropriate age, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
The vaccine which expired on 28-May-2023 was initially stored in refrigerator on 31-May-2023; No adverse event; An expired dose of Moderna bivalent vaccine was given. It expired 28-May-2023.; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (An expired dose of Moderna bivalent vaccine was given. It expired 28-May-2023.), PRODUCT STORAGE ERROR (The vaccine which expired on 28-May-2023 was initially stored in refrigerator on 31-May-2023) and NO ADVERSE EVENT (No adverse event) in a 38-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 016H22A) for COVID-19 prophylaxis.     It was reported that patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccines.  Previously administered products included for COVID-19 prophylaxis: Spikevax (Dose 1) and Spikevax (Dose 2). Past adverse reactions to the above products included No adverse event with Spikevax and Spikevax.    On 31-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 31-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (An expired dose of Moderna bivalent vaccine was given. It expired 28-May-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine which expired on 28-May-2023 was initially stored in refrigerator on 31-May-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (An expired dose of Moderna bivalent vaccine was given. It expired 28-May-2023.), PRODUCT STORAGE ERROR (The vaccine which expired on 28-May-2023 was initially stored in refrigerator on 31-May-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (An expired dose of Moderna bivalent vaccine was given. It expired 28-May-2023.) and PRODUCT STORAGE ERROR (The vaccine which expired on 28-May-2023 was initially stored in refrigerator on 31-May-2023).    Dosage text for suspect product was reported as unknown.  Concomitant drugs were not reported.  It was reported that the bivalent vial of 2.5 ml size was not exposed to temperature excursion.   Treatment medications were not provided.
She is worried it is a kind of blood clot.; She is worried it is a kind of blood clot.; Swollen lymph nodes in right leg; This is a spontaneous report from a contactable consumer(Patient).   A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 23May2021 as 2nd DOSE, Single for covid-19 immunization. Medical history included diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities, obesity. No family medical history reported. The patient's concomitant medications were not reported. Patient previously took historical vaccine of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm left on 02May2021 as single dose for covid-19 immunization. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. It was reported that, on 26May2021, after getting the second dose of the Covid vaccine, she had swollen lymph nodes in her right leg. She was worried and asks what to do and She asked if she needs to go to Urgent Care. she is worried it is a kind of blood clot. She asks if Pfizer will call her doctor and then call her. All she had were swollen lymph nodes. They are getting big and big. She confirms they are getting bigger. No relevant tests reported. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Information has been received from a physician concerning a 62 year old female who was vaccinated with a dose of zoster vaccine live (Oka/Merck). Subsequently the patient experienced rash and bad neuralgia. It is unknown if the patient sought medical attention. Additional information has been requested.
Same night as Men A/Flu Shot administered, patient had an itchy left face all night. When he woke up following morning Left facial cheek, red, mildly swollen, itchy. No anaphylaxis (no breathing difficulty/no tongue swelling). No fever, no neck pain. Otherwise fine.
Low grade fever, site of injection is red and hot and hard. Used ibuprofen and put compress on it.
itching on arms or legs, turns to hives if scratched periodically during the day.  seemed worse in December and January. Itching had be treated with Sarna lotion recommended by my Dermatologist.  Mentioned the itching to my primary care physician during my annual physical who suggested Claritin.  It is controlling the problem.  He indicated that he thought it might be a reaction to the booster.
Body aches, body pain, body rash, itching, nausea, joint aches.
Erythema, swelling, itchiness. Rx: Benadryl prn.
Mother unaware patient was provided 2nd dose seasonal FLUMIST to school initiative Nov. 3,'09. Present Nov. 17,'09 to have H1N1 2009 mist administered to patient, after patient was provided vaccine, informed mother once in the family car, she did receive 2nd dose of FLUMIST (seasonal) at school. Mother called the school nurse to verify then called the clinic to report.
27APR97 bumps noted around mouth, eyes, forearms & chest, upper thigh, abd, back;most concentration onchest & around eyes;now most concentrated around eyes, forearms & mouth;t103.8 ax;vomit 230MA 28APR;bumps-some raised-most not;
Hives and itching noticed about 2 hours after the vaccine. Cleared up some with Claritin. Pretty much gone the next day.
pt recvd vax & exp a bad case of itching all over 16hrs p/vax;treated self w/DPH for pruritus;itching stopped p/6hrs;
maybe a little low iron but not too remarkable; swelling in middle finger of right hand/puffiness in all of fingers and toes and around eyes; puffiness in all of fingers and toes and around eyes; she was not feeling great; fatigue; headache; soreness in her arm at the injection site; This is a spontaneous report from a contactable consumer. A 35-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) on her right arm, via an unspecified route of administration on 20Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that on 23Dec2020, she was not feeling great, had fatigue and headache. On 25Dec2020, she had swelling in her right middle finger, states that has now progressed to swelling in all her fingers, toes and around her eyes. Also reported that on 21Dec2020, she had soreness in her arm at the injection site that went away the same day. The patient also mentioned that she tested negative for Covid. The patient is also a little low iron but not too remarkable. The outcome of the event vaccination site pain was recovered in 21Dec2020, not recovered for peripheral swelling and puffy eyes while unknown for the other events.   Information on Lot/Batch has been requested.
01/16/22 Patient presents with shortness of breath.  Patient stated over the past four days he has been having subjective fevers, chills, headaches, nasal congestion, sore throat, cough.  Addition patient has generalized weakness with decreased appetite.  On presentation patient was satting 80% on room air requiring 2 L by nasal cannula.  Patient was diagnosed with acute hypoxic respiratory failure secondary to COVID-19 pneumonia causing COPD exacerbation. He was prescribed dexamethasone, and received IV Remdesvir.   He was readmitted on 1/28/22 he received 2 L IV fluids IV Rocephin Zithromax 2 g calcium gluconate, Chest x-ray showed bilateral interstitial infiltrates likely residual from covid infection. Pt stayed an additional 10 days in the hospital upon his second admission.
over 42 days. 1st dose 03/9/2021, 2nd dose 09/7/2021
patient walked into the post vaccination site. was sitting in chair states, "I am hot and thirsty" . Patient then went limp in chair. when called by name she woke up then lost consciousness. Patient was placed in a W/C brought into med room to lay down. pt awake and breathing VS taken. drinking water. Vs continued to be monitored .  Patient states, " I  am really lightheaded and do not feel well'. Rapid response called, patient taken to ER. on a gurney with 2 nurses.  Husband was notified, and updated.
Intense Flu-like symptoms for five days...low grade fever...one month later (beginning April 20) intense joint pain and soreness. Does not improve with 600 mg ibuprofen.
I immediately began feeling some mild/moderate symptoms (aches, chills, fatigue, etc.) after my shot on Tuesday, March 16th.  Whether this is related or not these symptoms moved to what I later learned to be appendicitis on or about Saturday, March 20th.  On March 22nd, my appendix ruptured and an appendectomy was performed the next morning.   I am not suggesting that there is a definitive causal relationship, but merely that it is very strange coincidence in case there are others.
At time of vaccination, I was bedridden for 6 days with brain fog and fatigue. A week later, I had my period on May 2nd, which was 5 days late, was more painful, heavier flow, brain fog, had positional vertigo that caused nausea and vomiting, still dealing with brain fog and fatigue 5 days later.